HROW.NASDAQHarrow, INC

Form 4: Harrow Inc. Director Perry Sternberg Reports Significant RSU Grant

Sentiment:

Insider Transaction Report


Harrow Inc. Director Perry J. Sternberg has reported the acquisition of 7,339 Restricted Stock Units as a compensatory award, vesting one year from the grant date of June 20, 2025.

Summary

  • Perry J. Sternberg, a Director and 10% Owner of Harrow, Inc. (HROW), reported the acquisition of 7,339 Restricted Stock Units (RSUs).
  • The transaction date, which is the grant date for these RSUs, was June 20, 2025.
  • The RSUs were received as a compensatory award for services rendered or to be rendered to the company.
  • The award vests in full on the one-year anniversary following the grant date, specifically on June 20, 2026.
  • The shares underlying these Restricted Stock Units will not be delivered to Mr. Sternberg and may not be transferred or sold until the termination of his service.
  • Following this reported transaction, Perry J. Sternberg beneficially owns 7,339 Restricted Stock Units directly.

Sentiment

Score: 6

Explanation: The filing is a routine disclosure of director compensation, which is generally viewed positively as it aligns director interests with shareholders, but it does not contain information that would significantly alter the company's financial outlook or operational status.

Positives

  • The grant of 7,339 Restricted Stock Units to Director Perry J. Sternberg aligns his interests with those of shareholders, as the value of the award is tied to the company's stock performance.
  • The compensatory nature of the award indicates ongoing commitment and value provided by the director to Harrow, Inc.

Negatives

  • The shares underlying the Restricted Stock Units are not delivered and cannot be transferred or sold until the termination of service, limiting immediate liquidity for the recipient.

Risks

  • The value of the Restricted Stock Units is subject to the future performance of Harrow, Inc.'s common stock, meaning the ultimate value realized by the director could be lower than the current market value if the stock price declines.
  • The vesting schedule requires continued service for one year, posing a risk of forfeiture if the director's service terminates before June 20, 2026.

Future Outlook

The Restricted Stock Units are scheduled to vest in full on June 20, 2026, contingent upon Perry J. Sternberg's continued service to Harrow, Inc. The shares underlying these units will only be delivered and become transferable upon the termination of his service.

Industry Context

The grant of Restricted Stock Units is a common practice in corporate compensation, particularly for directors and executives, designed to align their long-term interests with those of shareholders and to incentivize retention and performance within the pharmaceutical or healthcare industry, where Harrow, Inc. operates.

Related Party Transactions

  • The grant of 7,339 Restricted Stock Units to Director Perry J. Sternberg constitutes a related party transaction, representing compensation for services rendered or to be rendered.

Stakeholder Impact

  • Shareholders: The grant of equity to a director aligns their interests with shareholders, potentially incentivizing long-term value creation.
  • Employees: No direct impact on general employees mentioned.

Next Steps

  • The 7,339 Restricted Stock Units are scheduled to vest on June 20, 2026, at which point they will convert into common stock, subject to the director's continued service.

Key Dates

DateDescription
06/20/2025Date of grant for 7,339 Restricted Stock Units to Perry J. Sternberg.
06/24/2025Date the Form 4 was signed by Andrew R. Boll as Attorney in Fact for Perry J. Sternberg.
06/20/2026Vesting date for the 7,339 Restricted Stock Units (one-year anniversary of grant date).

Keywords

Harrow Inc., HROW, SEC Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Transaction, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.